市場調査レポート
商品コード
1081005

細胞培養用培地、血清、試薬市場 - 世界の業界分析、規模、シェア、成長、動向、予測(2021年~2031年)

Cell Culture Media, Sera, and Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 171 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
細胞培養用培地、血清、試薬市場 - 世界の業界分析、規模、シェア、成長、動向、予測(2021年~2031年)
出版日: 2022年04月14日
発行: Transparency Market Research
ページ情報: 英文 171 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要
当レポートでは、世界の細胞培養用培地、血清、試薬市場について調査し、市場の概要とともに、2021年~2031年の予測、製品別、特性別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー:世界の細胞培養用培地、血清、試薬市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の細胞培養用培地、血清、試薬市場の分析と予測、2017年~2031年

第5章 重要な洞察

第6章 世界の細胞培養用培地、血清、試薬市場の分析と予測、製品別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、製品別、2017年~2031年
    • 培地
    • 血清
    • 試薬
  • 市場の魅力分析

第7章 世界の細胞培養用培地、血清、試薬市場の分析と予測、エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、エンドユーザー別、2017~2031年
    • バイオテクノロジー企業、製薬会社
    • 学術研究機関
    • その他
  • 市場の魅力分析

第8章 世界の細胞培養用培地、血清、試薬市場の分析と予測、地域別

  • 主な調査結果
  • 市場価値予測、地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析

第9章 北米の細胞培養用培地、血清、試薬市場の分析と予測

第10章 欧州の細胞培養用培地、血清、試薬市場の分析と予測

第11章 アジア太平洋の細胞培養用培地、血清、試薬市場の分析と予測

第12章 ラテンアメリカの細胞培養用培地、血清、試薬市場の分析と予測

第13章 中東・アフリカの細胞培養用培地、血清、試薬市場の分析と予測

第14章 競合情勢

  • 市場参入企業-競合マトリクス
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Cytiva(Danaher Corporation)
    • Becton, Dickinson and Company
    • Corning Incorporated
    • HiMedia Laboratories
    • FUJIFILM Irvine Scientific, Inc.
    • InvivoGen
    • SeraCare(LGC Clinical Diagnostics, Inc.)
    • Lonza
図表

List of Table

  • Table 01: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 03: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 04: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 05: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017-2031
  • Table 06: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017-2031
  • Table 07: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 08: Global Cell Culture Media, Sera and Reagents Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 09: North America Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 10: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 11: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 12: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 13: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 14: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017-2031
  • Table 15: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017-2031
  • Table 16: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 19: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 20: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 21: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 22: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017-2031
  • Table 23: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017-2031
  • Table 24: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Asia Pacific Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 27: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 28: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 29: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 30: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017-2031
  • Table 31: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017-2031
  • Table 32: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 33: Latin America Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 34: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 35: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 36: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 37: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 38: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017-2031
  • Table 39: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017-2031
  • Table 40: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 41: Middle East & Africa Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 42: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 43: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017-2031
  • Table 44: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017-2031
  • Table 45: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017-2031
  • Table 46: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017-2031
  • Table 47: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017-2031
  • Table 48: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Cell Culture Media, Sera and Reagents Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Cell Culture Media, Sera and Reagents Market Value Share, by Region, 2020
  • Figure 03: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 04: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Media, 2017-2031
  • Figure 05: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Sera, 2017-2031
  • Figure 06: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Sera, 2017-2031
  • Figure 07: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 08: Global Cell Culture Media, Sera, and Reagents Market, by End-user, 2021-2031
  • Figure 09: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2017-2031
  • Figure 10: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Academic & Research Institutes, 2017-2031
  • Figure 11: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 12: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 13: Global Cell Culture Media, Sera, and Reagents Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 14: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 15: North America Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 16: North America Cell Culture Media, Sera and Reagents Market Analysis Value Share Analysis, by Country, 2020 and 2031
  • Figure 17: North America Cell Culture Media, Sera and Reagents Market Analysis Attractiveness Analysis, by Country 2021-2031
  • Figure 18: North America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 19: North America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 20: North America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 21: North America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 22: Europe Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: Europe Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 24: Europe Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 25: Europe Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 26: Europe Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 27: Europe Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 28: Europe Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 29: Asia Pacific Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: Asia Pacific Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 31: Asia Pacific Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 32: Asia Pacific Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 33: Asia Pacific Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 34: Asia Pacific Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 35: Asia Pacific Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 36: Latin America Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Latin America Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 38: Latin America Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 39: Latin America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 40: Latin America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 41: Latin America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 42: Latin America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 43: Middle East & Africa Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017-2031
  • Figure 44: Middle East & Africa Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 45: Middle East & Africa Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 46: Middle East & Africa Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 47: Middle East & Africa Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 48: Middle East & Africa Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 49: Middle East & Africa Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021-2031
目次
Product Code: TMRGL6598

Cell Culture Media, Sera, and Reagents Market - Scope of Report

TMR's report on the global cell culture media, sera, and reagents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global cell culture media, sera, and reagents market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cell culture media, sera, and reagents market from 2021 to 2031.

The report has been prepared after extensive research. Primary research involved the bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion-makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cell culture media, sera, and reagents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cell culture media, sera and reagents market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cell culture media, sera, and reagents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cell culture media, sera, and reagents market.

The report delves into the competitive landscape of the global cell culture media, sera, and reagents market. Key players operating in the global cell culture media, sera, and reagents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cell culture media, sera, and reagents market profiled in this report.

Key Questions Answered in Cell Culture Media, Sera, and Reagents Market Report

What will be the revenue generated by the cell culture media, sera, and reagents market across all regions during the forecast period?

What are key trends in the global cell culture media, sera, and reagents market?

What are major drivers, restraints, and opportunities in the global market?

Which region is set to expand at the highest CAGR during the forecast period?

Which segment of the Global cell culture media, sera, and reagents market will generate the maximum revenue by 2031?

Which segment will expand at the highest CAGR during the forecast period?

Cell Culture Media, Sera, and Reagents Market - Research Objectives and Research Approach

The comprehensive report on the global cell culture media, sera, and reagents market begins with an overview, followed by the scope and objectives of the study. The report provides a detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows a comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cell culture media, sera, and reagents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cell culture media, sera, and reagents market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cell Culture Media, Sera and Reagents Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. COVID-19 Impact Analysis

6. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Media
      • 6.3.1.1. Chemically-defined
      • 6.3.1.2. Classical Media
      • 6.3.1.3. Lysogeny Broth
      • 6.3.1.4. Protein Free
      • 6.3.1.5. Serum Free
      • 6.3.1.6. Specialty Media
    • 6.3.2. Sera
      • 6.3.2.1. Fetal Bovine
      • 6.3.2.2. Newborn Calf
      • 6.3.2.3. Others
    • 6.3.3. Reagents
      • 6.3.3.1. Albumin
        • 6.3.3.1.1. Human Serum Albumin
        • 6.3.3.1.2. Bovine Serum Albumin
        • 6.3.3.1.3. Recombinant Serum Albumin
      • 6.3.3.2. Amino Acids
      • 6.3.3.3. Attached Factors
      • 6.3.3.4. Growth Factors & Cytokines
        • 6.3.3.4.1. Transforming Growth Factor B1
        • 6.3.3.4.2. Epidermal Growth Factor
        • 6.3.3.4.3. Interleukins & Interferons
        • 6.3.3.4.4. Others
      • 6.3.3.5. Protease Inhibitors
      • 6.3.3.6. Thrombin
      • 6.3.3.7. Others
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Biotechnology & Pharmaceutical Companies
    • 7.3.2. Academic & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Cell Culture Media, Sera and Reagents Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product, 2017-2031
    • 9.2.1. Media
      • 9.2.1.1. Chemically-defined
      • 9.2.1.2. Classical Media
      • 9.2.1.3. Lysogeny Broth
      • 9.2.1.4. Protein Free
      • 9.2.1.5. Serum Free
      • 9.2.1.6. Specialty Media
    • 9.2.2. Sera
      • 9.2.2.1. Fetal Bovine
      • 9.2.2.2. Newborn Calf
      • 9.2.2.3. Others
    • 9.2.3. Reagents
      • 9.2.3.1. Albumin
        • 9.2.3.1.1. Human Serum Albumin
        • 9.2.3.1.2. Bovine Serum Albumin
        • 9.2.3.1.3. Recombinant Serum Albumin
      • 9.2.3.2. Amino Acids
      • 9.2.3.3. Attached Factors
      • 9.2.3.4. Growth Factors & Cytokines
        • 9.2.3.4.1. Transforming Growth Factor B1
        • 9.2.3.4.2. Epidermal Growth Factor
        • 9.2.3.4.3. Interleukins & Interferons
        • 9.2.3.4.4. Others
      • 9.2.3.5. Protease Inhibitors
      • 9.2.3.6. Thrombin
      • 9.2.3.7. Others
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Biotechnology & Pharmaceutical Companies
    • 9.3.2. Academic & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Cell Culture Media, Sera and Reagents Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Media
      • 10.2.1.1. Chemically-defined
      • 10.2.1.2. Classical Media
      • 10.2.1.3. Lysogeny Broth
      • 10.2.1.4. Protein Free
      • 10.2.1.5. Serum Free
      • 10.2.1.6. Specialty Media
    • 10.2.2. Sera
      • 10.2.2.1. Fetal Bovine
      • 10.2.2.2. Newborn Calf
      • 10.2.2.3. Others
    • 10.2.3. Reagents
      • 10.2.3.1. Albumin
        • 10.2.3.1.1. Human Serum Albumin
        • 10.2.3.1.2. Bovine Serum Albumin
        • 10.2.3.1.3. Recombinant Serum Albumin
      • 10.2.3.2. Amino Acids
      • 10.2.3.3. Attached Factors
      • 10.2.3.4. Growth Factors & Cytokines
        • 10.2.3.4.1. Transforming Growth Factor B1
        • 10.2.3.4.2. Epidermal Growth Factor
        • 10.2.3.4.3. Interleukins & Interferons
        • 10.2.3.4.4. Others
      • 10.2.3.5. Protease Inhibitors
      • 10.2.3.6. Thrombin
      • 10.2.3.7. Others
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Biotechnology & Pharmaceutical Companies
    • 10.3.2. Academic & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Cell Culture Media, Sera and Reagents Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Media
      • 11.2.1.1. Chemically-defined
      • 11.2.1.2. Classical Media
      • 11.2.1.3. Lysogeny Broth
      • 11.2.1.4. Protein Free
      • 11.2.1.5. Serum Free
      • 11.2.1.6. Specialty Media
    • 11.2.2. Sera
      • 11.2.2.1. Fetal Bovine
      • 11.2.2.2. Newborn Calf
      • 11.2.2.3. Others
    • 11.2.3. Reagents
      • 11.2.3.1. Albumin
        • 11.2.3.1.1. Human Serum Albumin
        • 11.2.3.1.2. Bovine Serum Albumin
        • 11.2.3.1.3. Recombinant Serum Albumin
      • 11.2.3.2. Amino Acids
      • 11.2.3.3. Attached Factors
      • 11.2.3.4. Growth Factors & Cytokines
        • 11.2.3.4.1. Transforming Growth Factor B1
        • 11.2.3.4.2. Epidermal Growth Factor
        • 11.2.3.4.3. Interleukins & Interferons
        • 11.2.3.4.4. Others
      • 11.2.3.5. Protease Inhibitors
      • 11.2.3.6. Thrombin
      • 11.2.3.7. Others
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Biotechnology & Pharmaceutical Companies
    • 11.3.2. Academic & Research Institutes
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of APAC
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Cell Culture Media, Sera and Reagents Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Media
      • 12.2.1.1. Chemically-defined
      • 12.2.1.2. Classical Media
      • 12.2.1.3. Lysogeny Broth
      • 12.2.1.4. Protein Free
      • 12.2.1.5. Serum Free
      • 12.2.1.6. Specialty Media
    • 12.2.2. Sera
      • 12.2.2.1. Fetal Bovine
      • 12.2.2.2. Newborn Calf
      • 12.2.2.3. Others
    • 12.2.3. Reagents
      • 12.2.3.1. Albumin
        • 12.2.3.1.1. Human Serum Albumin
        • 12.2.3.1.2. Bovine Serum Albumin
        • 12.2.3.1.3. Recombinant Serum Albumin
      • 12.2.3.2. Amino Acids
      • 12.2.3.3. Attached Factors
      • 12.2.3.4. Growth Factors & Cytokines
        • 12.2.3.4.1. Transforming Growth Factor B1
        • 12.2.3.4.2. Epidermal Growth Factor
        • 12.2.3.4.3. Interleukins & Interferons
        • 12.2.3.4.4. Others
      • 12.2.3.5. Protease Inhibitors
      • 12.2.3.6. Thrombin
      • 12.2.3.7. Others
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Biotechnology & Pharmaceutical Companies
    • 12.3.2. Academic & Research Institutes
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of LATAM
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Cell Culture Media, Sera and Reagents Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Media
      • 13.2.1.1. Chemically-defined
      • 13.2.1.2. Classical Media
      • 13.2.1.3. Lysogeny Broth
      • 13.2.1.4. Protein Free
      • 13.2.1.5. Serum Free
      • 13.2.1.6. Specialty Media
    • 13.2.2. Sera
      • 13.2.2.1. Fetal Bovine
      • 13.2.2.2. Newborn Calf
      • 13.2.2.3. Others
    • 13.2.3. Reagents
      • 13.2.3.1. Albumin
        • 13.2.3.1.1. Human Serum Albumin
        • 13.2.3.1.2. Bovine Serum Albumin
        • 13.2.3.1.3. Recombinant Serum Albumin
      • 13.2.3.2. Amino Acids
      • 13.2.3.3. Attached Factors
      • 13.2.3.4. Growth Factors & Cytokines
        • 13.2.3.4.1. Transforming Growth Factor B1
        • 13.2.3.4.2. Epidermal Growth Factor
        • 13.2.3.4.3. Interleukins & Interferons
        • 13.2.3.4.4. Others
      • 13.2.3.5. Protease Inhibitors
      • 13.2.3.6. Thrombin
      • 13.2.3.7. Others
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Biotechnology & Pharmaceutical Companies
    • 13.3.2. Academic & Research Institutes
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of MEA
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Company Profiles
    • 14.2.1. Thermo Fisher Scientific, Inc.
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Strategic Overview
    • 14.2.2. Merck KGaA
      • 14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.2.2. Product Portfolio
      • 14.2.2.3. SWOT Analysis
      • 14.2.2.4. Strategic Overview
    • 14.2.3. Cytiva (Danaher Corporation)
      • 14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.3.2. Product Portfolio
      • 14.2.3.3. SWOT Analysis
      • 14.2.3.4. Strategic Overview
    • 14.2.4. Becton, Dickinson and Company
      • 14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.4.2. Product Portfolio
      • 14.2.4.3. SWOT Analysis
      • 14.2.4.4. Strategic Overview
    • 14.2.5. Corning Incorporated
      • 14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.5.2. Product Portfolio
      • 14.2.5.3. SWOT Analysis
      • 14.2.5.4. Strategic Overview
    • 14.2.6. HiMedia Laboratories
      • 14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.6.2. Product Portfolio
      • 14.2.6.3. SWOT Analysis
      • 14.2.6.4. Strategic Overview
    • 14.2.7. FUJIFILM Irvine Scientific, Inc.
      • 14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.7.2. Product Portfolio
      • 14.2.7.3. SWOT Analysis
      • 14.2.7.4. Strategic Overview
    • 14.2.8. InvivoGen
      • 14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.8.2. Product Portfolio
      • 14.2.8.3. SWOT Analysis
      • 14.2.8.4. Strategic Overview
    • 14.2.9. SeraCare (LGC Clinical Diagnostics, Inc.)
      • 14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.9.2. Product Portfolio
      • 14.2.9.3. SWOT Analysis
      • 14.2.9.4. Strategic Overview
    • 14.2.10. Lonza
      • 14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.10.2. Product Portfolio
      • 14.2.10.3. SWOT Analysis
      • 14.2.10.4. Strategic Overview